FDA inspection
Casper Pharma Private Limited: FDA inspection ending Jul 12, 2024
FDA inspection 1243575 · Voluntary Action Indicated (VAI) · Rangareddy District
Key facts
| Inspection ID | 1243575 |
|---|---|
| Firm | Casper Pharma Private Limited |
| FEI number | 3019037664 |
| Address | Survey No. 99/1, Plot No-9a(1), Mamidipally Village, Balapur Mandal, Shamshabad |
| City | Rangareddy District |
| Country | India |
| Fiscal year | 2024 |
| Inspection end date | Jul 12, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data